Wikidata

(Q43254768)

English

Coexpression of CD44 variant isoforms and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status-independent predictor of poor outcome in diffuse large B-cell lymphomas

scientific article published in January 2010

In more languages

Statements

title
Coexpression of CD44 variant isoforms and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status-independent predictor of poor outcome in diffuse large B-cell lymphomas (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19857547
retrieved
17 November 2017
author name string
Sabine Nagel
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19857547
retrieved
17 November 2017
Petra Hirschmann
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
19857547
retrieved
17 November 2017
Stephan Dirnhofer
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
19857547
retrieved
17 November 2017
Ursula Günthert
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
19857547
retrieved
17 November 2017
publication date
1 January 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
19857547
retrieved
17 November 2017
page(s)
38-45
1 reference
stated in
Europe PubMed Central
PubMed ID
19857547
retrieved
17 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43254768&oldid=1984911445"